Foundry Partners, LLC Jazz Pharmaceuticals PLC Transaction History
Foundry Partners, LLC
- $1.95 Billion
- Q3 2024
A detailed history of Foundry Partners, LLC transactions in Jazz Pharmaceuticals PLC stock. As of the latest transaction made, Foundry Partners, LLC holds 3,362 shares of JAZZ stock, worth $404,414. This represents 0.02% of its overall portfolio holdings.
Number of Shares
3,362
Previous 3,031
10.92%
Holding current value
$404,414
Previous $323,000
15.79%
% of portfolio
0.02%
Previous 0.02%
Shares
2 transactions
Others Institutions Holding JAZZ
# of Institutions
516Shares Held
57.8MCall Options Held
188KPut Options Held
110K-
Black Rock Inc. New York, NY6.15MShares$739 Million0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA6.11MShares$735 Million0.01% of portfolio
-
Lsv Asset Management Chicago, IL2.49MShares$300 Million0.6% of portfolio
-
Pacer Advisors, Inc. Malvern, PA2.21MShares$266 Million0.67% of portfolio
-
State Street Corp Boston, MA1.95MShares$234 Million0.01% of portfolio
About Jazz Pharmaceuticals plc
- Ticker JAZZ
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 62,680,700
- Market Cap $7.54B
- Description
- Jazz Pharmaceuticals plc, a biopharmaceutical company, identifies, develops, and commercializes pharmaceutical products for various unmet medical needs in the United States, Europe, and internationally. The company has a portfolio of products and product candidates with a focus in the areas of neuroscience, including sleep medicine and movement ...